Recent developments in nanocarriers for cancer chemotherapy
Cancer is caused due to the unregulated proliferation of cells. Understanding the differences between a cancer cell and a normal cell; a normal tissue and a tumor microenvironment is the key to developing an efficient targeted drug delivery system for cancer therapy. With recent developments in canc...
Saved in:
Main Authors: | Debabrata Ghosh Dastidar (Author), Dipanjan Ghosh (Author), Amlan Das (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects
by: Mohamed A. A. Abdelhamid, et al.
Published: (2023) -
Recent developments in topoisomerase-targeted cancer chemotherapy
by: KirkE. Hevener, et al.
Published: (2018) -
Recent Advances in Zein-Based Nanocarriers for Precise Cancer Therapy
by: Wenquan Huang, et al.
Published: (2023) -
Nanocarriers containing platinum compounds for combination chemotherapy
by: Guihua Fang, et al.
Published: (2022) -
Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
by: Rajesh Pradhan, et al.
Published: (2023)